Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report. Before that can happen though, the U.S. government needs to grant the company approval, which is far from certain. In 2022, the U.S. Food and Drug Administration rejected its application to proceed with human trials due to safety concerns. Neuralink has been working to address those concerns ever since. 

Share:
More In Science
EPA Estimates 9.2M Lead Pipes Carry Water Into Homes
Some 9.2 million lead pipes carry water into homes across the U.S., with more in Florida than any other state, according to a new Environmental Protection Agency survey that will dictate how billions of dollars to find and replace those pipes are spent.
Load More